(Q46413137)
Statements
A Phase I clinical trial of ixabepilone (BMS-247550), an epothilone B analog, administered intravenously on a daily schedule for 3 days (English)
Susan Bates
Tito Fojo
Maureen Edgerly
Sen H Zhuang
Manish Agrawal
Susan Bakke
Herb Kotz
Paul Thambi